Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05000437
Other study ID # 20-09-1081
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2020
Est. completion date December 31, 2022

Study information

Verified date March 2023
Source Indonesia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Increased prevalence of overweight and obesity is one of the main health problems recently. Energy balance from nutrition intake and energy expenditure through physical activity, especially structured physical activity, is needed to prevent overweight individuals become obese individuals. This research objective is to explore the effectiveness and safety of structured high intensity interval training in male young adults subjects with overweight based on change of body composition, oxidative stress and inflammatory markers. This research used experimental model to test structured high intensity interval training program with pre-post test in single group. Comprehensive analysis of training effect in this research consists of measurement of several parameters, such as body composition, inflammatory markers, and oxidative stress markers as the benchmark of training safety. Browning white adipose tissue and cognitive function are complement parameters to the assessment of training effectiveness. Daily food record and physical activity for 3 x 24 hours will be carried out periodically to control confounding factors.


Description:

- Subjects are recruited via e-flyer distributed online across university departments. Individual who is interested in study participation fills out screening form. Research assistants screen subjects eligibility. Subjects are coded based on the order of screening form fulfillment. - Research assistants are using the standard operational procedures for each assessments. Training for the research assistants precedes the data collection to ensure the similarity of understanding and skills during measurements. One research assistant responsible for scheduling the assessments and training sessions. Continuous evaluation are planned weekly to provide room for improvements in the process of data collection. - Sample size assessment is measured from 5 primary output by a research assistants using sample size calculation website for single intervention clinical trial. - Investigator use paper based data collection for each assessment and during training sessions. Subject are encouraged to report any symptoms and signs during intervention period in each meeting with the research assistants or via online messaging. Any reports will be documented in separated form. One research assistant makes sure the data fields are completed in each measurements and during training sessions. The assistant also check the similarity of the data entered in the master table. - Data analysis will be lead by one research assistant using newest version of SPSS software. The analysis will be started after the baseline measurement is completed although the data collection is not finished. All numeric data will be presented as mean and standard deviations if normally distributed or median and minimum maximum range if not normally distributed. Paired t-test will be used to identify the difference before and after the intervention if the data are normally distributed. If the data are not normally distributed, Wilcoxon test will be used to identify the difference before and after the intervention. To ensure that there is no missing data, the research assistant who responsible for data completeness will perform daily checking. Any missing data will be stated and immediately completed. Research assistants will provide close supervision for each subject to ensure the delivery of all necessary reports.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date December 31, 2022
Est. primary completion date October 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: - overweight (BMI 25 - 29,9) - live in Jakarta and greater area - willing to participate Exclusion Criteria: - smoking - any medical health problems (epilepsy, cardiovascular disease, kidney and liver problems, history of fractures, tendon and ligament injuries)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
HIIT
3x/week high intensity interval training for 12 weeks

Locations

Country Name City State
Indonesia Fakultas Kedokteran Universitas Indonesia Jakarta Pusat DKI Jakarta
Indonesia Universitas Indonesia Jakarta Pusat DKI Jakarta

Sponsors (1)

Lead Sponsor Collaborator
Indonesia University

Country where clinical trial is conducted

Indonesia, 

Outcome

Type Measure Description Time frame Safety issue
Primary cardiorespiratory fitness VO2Max in ml/kg/minute 12 weeks
Primary body mass index weight and height combined as BMI in kg/m2 week 4
Primary body mass index weight and height combined as BMI in kg/m2 week 8
Primary body mass index weight and height combined as BMI in kg/m2 week 12
Primary body fat mass total fat mass in the body as percentage week 4
Primary body fat mass total fat mass in the body as percentage week 8
Primary body fat mass total fat mass in the body as percentage week 12
Primary visceral fat body fat stored within abdominal cavity as ratings week 4
Primary visceral fat body fat stored within abdominal cavity as ratings week 8
Primary visceral fat body fat stored within abdominal cavity as ratings week 12
Primary waist circumference circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm week 4
Primary waist circumference circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm week 8
Primary waist circumference circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm week 12
Primary lipid profile total cholesterol, HDL cholesterol, LDL cholesterol, triglyceride 12 weeks
Primary antioxidant level SOD in U/mg 12 weeks
Primary free radicals level MDA in nmol/mg 12 weeks
Primary inflammation TNF-alpha in microgram/ml 12 weeks
Primary interleukin level IL-6 nanogram/ml 12 weeks
Secondary Fat Burning Effect FGF21 week 1, 6, 12
Secondary Myokin Irisin week 1, 6, 12
Secondary Cognitive Function Screening Montreal Cognitive Assessment as score week 1 and 12
Secondary Working memory Capacity N-Back test as percentage of correct answers week 1 and 12
Secondary Executive Function Trail Making Test A and B as seconds week 1 and 12
See also
  Status Clinical Trial Phase
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Terminated NCT03299881 - Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss N/A
Completed NCT02805478 - Fat-Associated Cardiovascular Organ Dysfunction
Active, not recruiting NCT02558920 - Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
Completed NCT03759743 - Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject N/A
Completed NCT03610958 - Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss. N/A
Completed NCT03678766 - CHARGE: Controlling Hunger and ReGulating Eating N/A
Completed NCT04430465 - Effects of Wholegrains on Children's Health (KORN) N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT05376865 - Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers N/A
Completed NCT03625427 - Effect of Palmitoleic Acid on C-reactive Protein N/A
Active, not recruiting NCT03435445 - Online Platform for Healthy Weight Loss (POEmaS) N/A
Enrolling by invitation NCT05576116 - Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics N/A
Recruiting NCT05249465 - Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention N/A
Active, not recruiting NCT06023095 - A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities Phase 1
Completed NCT03648892 - Brain Dopamine Function in Human Obesity Early Phase 1
Recruiting NCT02887950 - Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause N/A
Completed NCT02899390 - Diabetes Prevention Program in Adults of the Yaqui Tribe of Hermosillo, Sonora at Risk of Diabetes N/A
Completed NCT03097237 - High Fiber Rye Foods for Weight and Body Fat Reduction N/A
Terminated NCT02743598 - Liraglutide for HIV-associated Neurocognitive Disorder Phase 4